Label: SARNA- pramoxine hydrochloride lotion
- NDC Code(s): 0316-0230-12, 0316-0230-57
- Packager: Crown Laboratories
- Category: HUMAN OTC DRUG LABEL
- DEA Schedule: None
Drug Label Information
Updated May 30, 2024
If you are a consumer or patient please visit this version.
- Download DRUG LABEL INFO: PDF XML
- Official Label (Printer Friendly)
- Active ingredient
- Purpose
- Uses
- Warnings
- Directions
- Other information
-
Inactive ingredients
Aloe Barbadensis Leaf Juice, Benzyl Alcohol, Beta-Glucan, C12-18 Alkanoyl Glycerin/Sebacic Acid Copolymer, Caprylyl Glycol, Carbomer, Cetyl Alcohol, Citric Acid, Dimethicone, Ethylhexylglycerin, Glyceryl Stearate, Isopropyl Myristate, Palmitic Acid, PEG-100 Stearate, PEG-8 Stearate, Pentylene Glycol, Saccharide Isomerate, Simmondsia Chinensis (Jojoba) Seed Oil, Sodium Citrate, Sodium Hydroxide, Squalane, Stearic Acid, Tocopherol, Water
-
Sarna Sensitive Principal Display Panel
#1 DERMATOLOGIST RECOMMENDED TOPICAL ANTI-ITCH BRAND
Sarna
Pramoxine Hydrochloride 1%
External Analgesic Lotion
Steroid Free
SENSITIVE
ANTI-ITCH LOTION
- Eases itch associated with minor skin irritations
- Soothes and conditions with Aloe, Squalene, and Jojoba Oil
- Hypoallergenic
NET WT. 7.5fl oz (222 ml)
-
INGREDIENTS AND APPEARANCE
SARNA
pramoxine hydrochloride lotionProduct Information Product Type HUMAN OTC DRUG Item Code (Source) NDC:0316-0230 Route of Administration TOPICAL Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength PRAMOXINE HYDROCHLORIDE (UNII: 88AYB867L5) (PRAMOXINE - UNII:068X84E056) PRAMOXINE HYDROCHLORIDE 10 mg in 1 mL Inactive Ingredients Ingredient Name Strength SODIUM HYDROXIDE (UNII: 55X04QC32I) BENZYL ALCOHOL (UNII: LKG8494WBH) PENTYLENE GLYCOL (UNII: 50C1307PZG) SACCHARIDE ISOMERATE (UNII: W8K377W98I) GLYCERYL MONOSTEARATE (UNII: 230OU9XXE4) ALOE VERA LEAF (UNII: ZY81Z83H0X) ETHYLHEXYLGLYCERIN (UNII: 147D247K3P) SIMMONDSIA CHINENSIS SEED (UNII: D24K2Q1F6H) TOCOPHEROL (UNII: R0ZB2556P8) WATER (UNII: 059QF0KO0R) PEG-100 STEARATE (UNII: YD01N1999R) PEG-8 STEARATE (UNII: 2P9L47VI5E) SQUALANE (UNII: GW89575KF9) CAPRYLYL GLYCOL (UNII: 00YIU5438U) ISOPROPYL MYRISTATE (UNII: 0RE8K4LNJS) PALMITIC ACID (UNII: 2V16EO95H1) SODIUM CITRATE (UNII: 1Q73Q2JULR) CARBOMER HOMOPOLYMER TYPE C (UNII: 4Q93RCW27E) CETYL ALCOHOL (UNII: 936JST6JCN) CITRIC ACID MONOHYDRATE (UNII: 2968PHW8QP) YEAST .BETA.-D-GLUCAN (UNII: 44FQ49X6UN) DIMETHICONE (UNII: 92RU3N3Y1O) STEARIC ACID (UNII: 4ELV7Z65AP) Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:0316-0230-57 222 mL in 1 BOTTLE, PUMP; Type 0: Not a Combination Product 01/01/2024 2 NDC:0316-0230-12 355 mL in 1 BOTTLE, PUMP; Type 0: Not a Combination Product 01/01/2024 Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date OTC Monograph Drug M017 01/01/2024 Labeler - Crown Laboratories (079035945) Establishment Name Address ID/FEI Business Operations Crown Laboratories, Inc. 079035945 manufacture(0316-0230) Establishment Name Address ID/FEI Business Operations VOYANT BEAUTY, INC. 243547333 manufacture(0316-0230)